Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle rad51'

Search results for: 'research area cell cycle rad51'

10 Items

per page
  1. RG7112
    A3762 RG7112
     5 Citation
    Target: MDM2
    Summary: MDM2 inhibitor, first clinical
      ≥36.4 mg/mL
  2. Q-VD-OPh
    A1901 Q-VD-OPh
     53 Citation
    Target: Caspases
    Summary: Cell-permeable, irreversible pan-caspase inhibitor
      ≥25.67 mg/mL
  3. Z-DEVD-FMK
    A1920 Z-DEVD-FMK
     12 Citation
    Target: Caspases
    Summary: Caspase-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
  4. AMG232
    A8804 AMG232
     2 Citation
    Target: p53-MDM2 interaction
    Summary: p53-MDM2 inhibitor, novel
      Soluble in DMSO
  5. HA14-1
    A8168 HA14-1
    Target: Bcl-2
    Summary: Bcl-2 inhibitor,potent and cell-permeable
      insoluble in H2O; ≥20.45 mg/mL
  6. Doxifluridine
    B2092 Doxifluridine
    Summary: oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)
      insoluble in EtOH; ≥10 mg/mL
  7. Nonivamide (Capsaicin Analog)
    A3278 Nonivamide (Capsaicin Analog)
     1 Citation
    Target: TRP Channel
    Summary: TRPV1 receptor agonist
      insoluble in H2O; ≥15.27 mg/mL
  8. ABT-263 (Navitoclax)
    A3007 ABT-263 (Navitoclax)
     15 Citation
    Target: Bcl-2|Bcl-w
    Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
      ≥48.73 mg/mL
  9. WEHI-539
    A3935 WEHI-539
     15 Citation
    Target: Bcl-xl
    Summary: Bcl-xL inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  10. PAC-1
    A8177 PAC-1
     1 Citation
    Target: Caspases
    Summary: Procaspase-3 activator
      insoluble in H2O; ≥13.4 mg/mL

10 Items

per page